Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out


March20 podcast Dr Hazen
anti-TMA pill in a year or 2 ? (scroll 12 mins)

Additional info:
MEBO Karen
at UK Findacure conf 2020

Scroll down and select country

MEBO Map Testing & Meetups

Full details :
want listed ? contact

MEBO - UBIOME study 2018



MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person


Participation info : LINK English

MEBO Private Facebook Group
to join : go to
or contact
Join/Watch the weekly
BO Sufferers Podcasts



TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned

Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
NORD Member Organization
See RareConnect TMAU

Popular Posts (last 30 days)

Upcoming get-togethers

Let us know if you want a meetup listed
Follow MeBOResearch on Twitter

Blog Archive

Denver TMAU Test Lab survey click here
click to Read more/less

USA survey for anyone who wants to improve Denver TMAU test

begun : Dec22
end : no ending for now

A trainee genetic counselor is working at the Denver TMAU test lab. Probably as part of her training. As a project she wishes feedback on any aspect of the Denver TMAU test and process. You can fill in the survey and/or email her (email address is in survey). It's meant for USA people, but perhaps others can give their view too (as we have so few opportunities).

quote from her rareconnect post

"Hello all! I wanted to make you aware of a research study being conducted to better understand the experience and needs of individuals with trimethylaminuria with a goal of being able to create improved patient and healthcare provider education materials. Any participation is completely voluntary and all responses remain confidential. Feel free to use the contact information within the link with any questions or share the survey with others with TMAU."

see this post for more details

Wednesday, June 11, 2014

RareConnect sponsored Webinar: Exploratory Breath Study

RareConnect sponsored Webinar
DATE: July 11, 2014
NEW DATE: Thursday, JULY 17, 2014

TIME: 2:00pm Eastern Daylight Time (EDT)
See The World Clock - Time Zones


Topic of Discussion:
The exploratory breath study and general initiatives of the Menssana Research Team with Michael Phillips MD, FACP, FRCP Founder & CEO Menssana Research and other staff.

Click icon
for blog posts on study

Menssana Exploratory Breath Study

In sticking with MEBO RESEARCH'S MISSION, “to initiate research into rare genetic metabolic diseases, particularly those resulting in systemic, difficult to control body malodor and halitosis, including, but not limited to, Trimethylaminuria”, in mid 2012 MEBO partnered with Dr. Michael Phillips, MD, PACP, Professor of Clinical Medicine at New York Medical College, Valhalla, New York, an expert in breath testing, to offer breath testing to our community - to explore biomarkers for body odor and halitosis. MEBO’s primary role was to facilitate testing with patients to make testing available to communities where there was enough demand. There were many hurdles including significant cost suffered by MEBO in shipping the BCA instrument; however, we are happy to say there were 30 participants that traveled to Chicago, Miami, New York, and London. Each participant received his or her testing results shortly after testing, showing over 200+ compounds. We thank each participant for their tireless efforts in the breath testing collection process. We achieved the minimal amount of patients required for a small study of the aggregate test results.

As part of the initial agreement, Menssana Research was to evaluate the aggregate test results along with the questionnaires filled out by each participant for our community and provide feedback of any indicators of odorous compounds in the breath. The following is what we received from Dr. Phillips describing the next steps of the study. This will require additional funding from our supporters in the community to continue progress and to utilize the data set we collected so far to continue to track down odor causes.

I enjoyed speaking with you again today. As we discussed, our pilot study generated an enormous amount of data but it was difficult to extract a signal of body odor. The reason is that each breath test with GCxGC TOF MS detects around 2,000 different volatile organic compounds (VOCs), and these would need to be compared statistically to the VOC profile in normals. In order to do this, we would need to design a careful study to re-analyze the data:
1. Data will be clinically stratified into comparable groups (oral odor, body odor etc)
2. Data will be sent for alignment (MEBO plus normals) to chromatography consultant
3. Statistician will perform Monte Carlo analysis of aligned data
4. We will use this information to ID biomarkers of body odor

The methods are all described in recent publications at

This study may not provide all of the answers we seek, because the number of subjects studied was comparatively small - around 30. But at least the results should point us in the right direction for future studies. We will prepare a proposal for you soon.

Best regards,

Not the exact news we had hoped for, however, we are waiting for a cost proposal so we can figure out fundraising efforts in case the community would like to pursue. As soon as we receive the cost proposal, we will make it available to the community. We are also pending receipt of the raw data in the case we pursue independent research.


The good news is that we have collaborated with Dr. Phillips and the Menssana team to conduct a Webinar on Friday, July 11, 2014 at 2:00pm EST for the community on Rareconnect to discuss breath testing and general initiatives of the Menssana team. We think this is important to introduce Menssana, understand the technology being used, and learn general initiatives/discoveries of the team. Additionally, it gives the community an opportunity to ask Dr. Phillips any questions.

MEBO has placed major efforts in contacting and establishing a relationship with scientists, researchers, doctors, and other experts to establish quality testing and research, so that our community can find answers to systemic types of odors. With the continued patience of the community, MEBO will continue its efforts in maintaining a proactive stance.


María de la Torre
Founder and Executive Director

A Public Charity (em português)
MEBO's Blog (English)
El Blog de MEBO (español)

SUPPORT THE MEBO MISSION: Click Amazon button at right sidebar of this blog when shopping online for the holidays
at no extra cost to you.
MEBO gets small commission from Amazon.

Please use your credit card to make your donation to MEBO.

Subscribe for latest posts : Enter your email address:

Delivered by FeedBurner


Post a Comment